BJH - volume 15, issue 8, december 2024
J. Blokken PhD, PharmD
OVERVIEW OF BELGIAN REIMBURSEMENT NEWS
(BELG J HEMATOL 2024;15(8):333–4)
Read moreBJH - volume 15, issue 7, november 2024
J. Blokken PhD, PharmD
OVERVIEW OF BELGIAN REIMBURSEMENT NEWS
(BELG J HEMATOL 2024;15(7):302)
Read moreBJH - volume 15, issue 6, october 2024
J. Blokken PhD, PharmD
OVERVIEW OF BELGIAN REIMBURSEMENT NEWS
(BELG J HEMATOL 2024;15(6):257)
Read moreBJH - volume 15, issue 5, september 2024
J. Collins PhD, J. Blokken PhD, PharmD
Myeloid malignancies encompass a group of haematopoietic disorders including acute myeloid leukaemia (AML), myeloproliferative neoplasms, and myelodysplastic syndrome (MDS). At EHA 2024, the most recent updates in the area of myeloid malignancies were presented.
(BELG J HEMATOL 2024;15(5):205–10)
Read moreBJH - volume 15, issue 4, june 2024
J. Blokken PhD, PharmD
In this section of the Belgian Journal of Hematology (BJH), we aim to provide a snapshot of pivotal studies published in recent issues of the most important international journals focusing on haematology. Importantly, the selection of the studies discussed here is the sole responsibility of the publisher and was not influenced by third parties. Do you miss an important study, or did you read a hidden jewel that deserves to be shared with your colleagues? Please, let us know (editor@bjh.be) and we will make sure to include it in the journal scan section of the next BJH issue.
(BELG J HEMATOL 2024;15(4):176–9)
Read moreBJH - 2024, issue Special, may 2024
J. Blokken PhD, PharmD, T. Feys MBA, MSc
In recent years, the treatment landscape of patients with relapsed or refractory diffuse-large B-cell lymphoma (R/R DLBCL) has changed dramatically. This mini review will briefly discuss the clinical trial data that were obtained with these different options.
Read moreBJH - volume 15, issue 2, march 2024
A. Enguita PhD, J. Blokken PhD, PharmD
In this section of the Belgian Journal of Hematology (BJH), we aim to provide a snapshot of pivotal studies published in recent issues of the most important international journals focusing on haematology. Importantly, the selection of the studies discussed here is the sole responsibility of the publisher and was not influenced by third parties. Do you miss an important study, or did you read a hidden jewel that deserves to be shared with your colleagues? Please, let us know (editor@bjh.be) and we will make sure to include it in the journal scan section of the next BJH issue.
(BELG J HEMATOL 2024;15(2):58–61)
Read more
Top
